Emergence of multidrug-resistant mutants is increased under antibiotic selective pressure in Pseudomonas aeruginosa

Microbiology

Volumn 145, Issue 10, 1999, Pages 2857-2862

  Alonso, Ana ^a   Campanario, Ester ^a   Martínez, José L ^a  

^a CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

Author keywords

Adaptive mutation; Antibiotic resistance; MDR; Mutation rate; Pseudomonas aeruginosa

Indexed keywords

ANTIBIOTIC AGENT; OUTER MEMBRANE PROTEIN; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL MUTATION; BACTERIUM MUTANT; HOSPITAL INFECTION; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA;

EID: 0032860807     PISSN: 13500872     EISSN: None     Source Type: Journal    
DOI: 10.1099/00221287-145-10-2857     Document Type: Article

References (37)

1. Atlas, R. M. (1993). Handbook of Microbiological Media. London : CRC Press.
2. Baquero, F. & Blazquez, J. (1997). Evolution of antibiotic resistance. Trends Ecol Evol 12, 482-487.
3. Baquero, F., Negri, M. C., Morosini, M. I. & Blazquez, J. (1997). The antibiotic selective process: concentration-specific amplification of low-level resistant populations. Ciba Found Symp 207, 93-105.
4. Bonhoeffer, S., Lipsitch, M. & Levin, B. R. (1997). Evaluating treatment protocols to prevent antibiotic resistance. Proc Natl Acad Sci USA 94, 12106-12111.
5. Cairns, J. & Foster, P. L. (1991). Adaptive reversion of a frameshift mutation in Escherichia coli. Genetics 128, 695-701.
6. Clerch, B., Barbe, J. & Llagostera, M. (1992). The role of the excision and error-prone repair systems in mutagenesis by fluorinated quinolones in Salmonella typhimurium. Mutat Res 281, 207-213.
7. Deguchi, T., Kawamura, T., Yasuda, M., Nakano, M., Fukuda, H., Kato, H., Kato, N., Okano, Y. & Kawada, Y. (1997). In vivo selection of Klebsiella pneumoniae strains with enhanced quinolone resistance during fluoroquinolone treatment of urinary tract infections. Antimicrob Agents Chemother 41, 1609-1611.
8. Everett, M. J., Jin, Y. F., Ricci, V. & Piddock, L. J. V. (1996). Contributions of individual mechanisms to fluoroquinolone resistance in 36 Escherichia coli strains isolated from humans and animals. Antimicrob Agents Chemother 40, 2380-2386.
9. Fukuoka, T., Masuda, N., Takenouchi, T., Sekine, N., Iijima, M. & Ohya, S. (1991). Increase in susceptibility of Pseudomonas aeruginosa to carbapenem antibiotics in low-amino-acid media. Antimicrob Agents Chemother 35, 529-532.
10. Gottesman, M. M., Hrycyna, C. A., Schoenlein, P. V., Germann, U. A. & Pastan, I. (1995). Genetic analysis of the multidrug transporter. Annu Rev Genet 29, 607-649.
11. Govan, J. R. & Nelson, J. W. (1992). Microbiology of lung infection in cystic fibrosis. Br Med Bull 48, 912-930.
12. Kanematsu, E., Deguchi, T., Yasuda, M., Kawamura, T., Nishino, Y. & Kawada, Y. (1998). Alterations in the GyrA subunit of DNA gyrase and the ParC subunit of DNA topoisomerase IV associated with quinolone resistance in Enterococcus faecalis. Antimicrob Agents Chemother 42, 433-435.
13. Kasak, L., Horak, R. & Kivisaar, M. (1997). Promoter-creating mutations in Pseudomonas putida : a model system for the study of mutation in starving bacteria. Proc Natl Acad Sci USA 94, 3134-3139.
14. Kerem, B., Rommens, J. M., Buchanan, J. A., Markiewicz, D., Cox, T. K., Chakravarti, A., Buchwald, M. & Tsui, L. C. (1989). Identification of the cystic fibrosis gene: genetic analysis. Science 245, 1073-1080.
15. Köhler, T., Michea-Hamzehpour, M., Henze, U., Gotoh, N., Curty, L. K. & Pechère, J. C. (1997a). Characterization of MexE-MexF-OprN, a positively regulated multidrug efflux system of Pseudomonas aeruginosa. Mol Microbiol 23, 345-354.
16. Köhler, T., Michea-Hamzehpour, M., Plesiat, P., Kahr, A. L & Pechère, J. C. (1997b). Differential selection of multidrug efflux systems by quinolones in Pseudomonas aeruginosa. Antimicrob Agents Chemother 41, 2540-2543.
17. McKenzie, G. J., Lombardo, M. J. & Rosenberg, S. M. (1998). Recombination-dependent mutation in Escherichia coli occurs in stationary phase. Genetics 149, 1163-1165.
18. Maenhaut-Michel, G. & Shapiro, J. A. (1994). The roles of starvation and selective substrates in the emergence of araB-lacZ fusion clones. EMBO J 13, 5229-5239.
19. Martínez, J. L., Alonso, A., Gómez-Gómez, J. M. & Baquero, F. (1998). Quinolone resistance by mutations in chromosomal gyrase genes. Just the tip of the iceberg? J Antimicrob Chemother 42, 683-688.
20. Mittler, J. E. & Lenski, R. E. (1990). New data on excisions of Mu from E. coli MCS2 cast doubt on directed mutation hypothesis. Nature 344, 173-175.
21. National Committee for Clinical Laboratory Standards (1997). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically, 4th edn. Approved standard M7 A4. Wayne, PA, USA.
22. Nikaido, H. (1994). Prevention of drug access to bacterial targets : permeability barriers and active efflux. Science 264, 382-388.
23. Ostroff, R. M., Wretlind, B. & Vasil, M. L. (1989). Mutations in the hemolytic-phospholipase C operon result in decreased virulence of Pseudomonas aeruginosa PAO1 grown under phosphate-limiting conditions. Infect Immun 57, 1369-1373.
24. Poole, K., Krebes, K., McNally, C. & Neshat, S. (1993). Multiple antibiotic resistance in Pseudomonas aeruginosa: evidence for involvement of an efflux operon. J Bacteriol 175, 7363-7372.
25. Poole, K., Gotoh, N., Tsujimoto, H. & 7 other authors (1996). Overexpression of the mexC-mexD-oprJ efflux operon in nfxB-type multidrug-resistant strains of Pseudomonas aeruginosa. Mol Microbiol 21, 713-724.
26. Quinn, J. P. (1998). Clinical problems posed by multiresistant nonfermenting gram-negative pathogens. Clin Infect Dis 27, S117-S124.
27. Riesenfeld, C., Everett, M., Piddock, L. J. & Hall, B. G. (1997). Adaptive mutations produce resistance to ciprofloxacin. Antimicrob Agents Chemother 41, 2059-2060.
28. Rosenberg, S. M. (1997). Mutation for survival. Curr Opin Genet Dev 7, 829-834.
29. Saier, M. H., Jr, Paulsen, I. T., Sliwinski, M. K., Pao, S. S., Skurray, R. A. & Nikaido, H. (1998). Evolutionary origins of multidrug and drug-specific efflux pumps in bacteria. FASEB J 12, 265-274.
30. Sferra, T. J. & Collins, F. S. (1993). The molecular biology of cystic fibrosis. Annu Rev Med 44, 133-144.
31. Shapiro, J. A. (1984). Observations on the formation of clones containing araB-lacZ cistron fusions. Mol Gen Genet 194, 79-90.
32. Shapiro, J. A. (1993). Natural genetic engineering of the bacterial genome. Curr Opin Genet Dev 3, 845-848.
33. Shapiro, J. A. (1997). Genome organization, natural genetic engineering and adaptive mutation. Trends Genet 13, 98-104.
34. Sniegowski, P. D. (1995). A test of the directed mutation hypothesis in Escherichia coli MCS2 using replica plating. J Bacteriol 177, 1119-1120.
35. Torkelson, J., Harris, R. S., Lombardo, M. J., Nagendran, J., Thulin, C. & Rosenberg, S. M. (1997). Genome-wide hypermutation in a subpopulation of stationary-phase cells underlies recombination-dependent adaptive mutation. EMBO J 16, 3303-3311.
36. Wang, T., Tanaka, M. & Sato, K. (1998). Detection of grlA and gyrA mutations in 344 Staphylococcus aureus strains. Antimicrob Agents Chemother 42, 236-240.
37. Wiedemann, B. & Heisig, P. (1994). Mechanisms of quinolone resistance. Infection 22, S73-S79.